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Abstract
Background: Stem cells reside in a plant’s shoot meristem throughout its life and are main regulators of above-
ground plant development. The stem cell maintenance depends on a feedback network between the CLAVATA
and WUSCHEL genes. The CLAVATA3 peptide binds to the CLAVATA1 receptor leading to WUSCHEL inhibition.
WUSCHEL, on the other hand, activates CLAVATA3 expression. Recent experiments suggest a second pathway
where CLAVATA3 inhibits WUSCHEL via the CORYNE receptor pathway. An interesting question, central for
understanding the receptor signaling, is why the clavata1-11 null mutant has a weaker phenotype compared with
the clavata1-1 non-null mutant. It has been suggested that this relies on interference from the mutated CLAVATA1
acting on the CORYNE pathway.
Results: We present two models for the CLAVATA-WUSCHEL feedback network including two receptor pathways
for WUSCHEL repression and differing only by the hypothesized mechanisms for the clavata1-1 non-null mutant.
The first model is an implementation of the previously suggested interference mechanism. The other model
assumes an unaltered binding between CLAVATA3 and the mutated CLAVATA1 but with a loss of propagated
signal into the cell. We optimize the models using data from wild type and four single receptor mutant
experiments and use data from two receptor double mutant experiments in a validation step. Both models are
able to explain all seven phenotypes and in addition qualitatively predict CLAVATA3 perturbations. The two models
for the clavata1-1 mutant differ in the direct mechanism of the mutant, but they also predict other differences in
the dynamics of the stem cell regulating network. We show that the interference hypothesis leads to an
abundance of receptors, while the loss-of-signal hypothesis leads to sequestration of CLAVATA3 and relies on
degradation or internalization of the bound CLAVATA1 receptor.
Conclusions: Using computational modeling, we show that an interference hypothesis and a more parsimonious
loss-of-signal hypothesis for a clavata1 non-null mutant both lead to behaviors predicting wild type and six
receptor mutant experiments. Although the two models have identical implementations of the unperturbed
feedback network for stem cell regulation, we can point out model-predicted differences that may be resolved in
future experiments.
Background
The development of animals and plants is dependent on
undifferentiated stem cells residing in special locations
called niches [1]. In a plant, stem cells are maintained in
the shoot apical meristem (SAM) throughout its life,
and the SAM is the source of all aerial parts of the
plant [2,3].
Spatial regions of different expression patterns and
functions are found within the SAM. The central zone
is located at the tip of the apex and consists of slowly
dividing stem cells expressing the CLAVATA3 (CLV3)
gene. Due to cellular growth and proliferation, stem
cells from the central zone move into the surrounding
tissue where the spatial location of each daughter cell is
a main determinant of cell fate. Located below the cen-
tral zone is a small group of cells that are believed to
form a control zone for the organization of the SAM.
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encodes a homeodomain transcription factor and has
been shown to be required for maintaining stem cells in
the shoot [4]. Although not expressed in the same cells,
WUS and CLV3 regulate the expression of each other.
While WUS upregulates CLV3, the intercellular peptide
CLV3 acts together with the receptor kinase CLA-
VATA1 (CLV1) in a signaling pathway that downregu-
lates WUS [4-7]. This feedback network is a main
regulator of stem cell maintenance in the SAM. If the
number of stem cells is low the CLV3 signal will be
weak and expression of WUS will in-crease, which in
turn will induce CLV3 expression. If instead there is an
abundance of stem cells, WUS will be downregulated
and CLV3 expression will decrease.
Additional molecules have been identified to be
important for SAM development. The receptor-like
CLAVATA2 (CLV2) is involved in WUS repression act-
ing within the CLV3 signaling path-way [8]. Müller
et al. (2008, 2009) [9,10] recently identified a kinase
CORYNE (CRN) that interacts with CLV2 and together
form a receptor for CLV3. In addition, the BAM family
of receptors has an antagonistic effect compared to
CLAVATA1 in stem cell regulation [11,12], and several
members of the CLE (CLAVATA3/ESR-related) ligand
family were shown to affect the SAM development in
perturbation assays [13]. The intracellular components
o ft h eW U S - r e p r e s s i n gs i g n a la r et oal a r g ee x t e n t
unknown, but POLTERGEIST (POL) and POLTERGE-
IST-LIKE1 (PLL1) have been shown to be important for
mediating the signal [14]. In addition, hormonal signal-
ing and chromatin remodeling has been implicated in
the regulation of WUSCHEL [15-17].
Reduction in CLAVATA signaling leads to increased
WUS and CLV3 expressions and an increase in number
of stem cells and shoot size [18] as well as an increased
number of carpels produced in flowers. A number of clv1
alleles have been shown to have different strengths in
these phenotypic traits. Somewhat unintuitively, the clv1-
11 null-mutant was shown to have a weaker phenotype
than the non-null clv1-1 mutant [19]. Müller et al. (2008)
[9] also found that the crn-1 clv1-1 double mutant
showed weaker phenotype than the crn-1 clv1-11 double
mutant. It was suggested that the stronger phenotype of
the clv1-1 mutant compared to the null mutant is due to
a functional overlap between multiple receptors, and that
t h ed o m i n a n te f f e c to fclv1-1 could relate to cross-talk
with other receptors [19]. With the identification of
CRN/CLV2, this receptor was suggested to be the target
for interference by the mutated CLV1 [9].
Several theoretical models have been used to investi-
gate different aspects of the stem cell regulatory network
in the SAM [20]. For example, spatial models using sta-
tic cell-based SAM templates have been used to
investigate how the WUS-activated CLV3 expression
region could be localized to the central zone, and how
WUS may be spatially activated via a pattern-forming
mechanism [21-23]. The intracellular WUS activation
network has been further investigated showing the
importance of the hormone cytokinin for WUS activa-
tion [15], and a cell-population based model has been
used to investigate uncoupling of the sizes of the CLV3
and WUS domains at different growth conditions [24].
None of the published models have included multiple
receptor pathways for the WUS-repressing signal, and in
this paper we use computational modeling to investigate
details of receptor and ligand turnover, interactions, and
signaling. We focus on the differences in receptor
mutants, where the main question is how a clv1-11 null
mutant can have a weaker phenotype than a clv1-1 non-
null mutant in the context of phenotypes for a number
of single and double receptor mutants. We develop two
models capturing the main aspects of the negative feed-
back loop for stem cell regulation. In the models, CLV3
binds to both CLV1 and CRN/CLV2 receptors, the
bound receptors propagate a combined signal repressing
WUS, and WUS induces CLV3 production. The two
models only differ in the implementation of the clv1-1
non-null mutant. The first model is used to test the pro-
posed idea of receptor interference as an explanation of
the differences in phenotypes of clv1 mutants and the
second model is used to test a more parsimonious loss-
of-signal mutant hypothesis. A motivation for the sec-
ond model is that the clv1-1 has been identified as a
missense mutation in the kinase part of the receptor
[19].
A common problem for modeling biological systems is
the abundance of unknown values for the kinetic reac-
tion parameters. To address this problem we use a para-
meter ensemble approach, where we for each model
extract a number of parameter sets, chosen for the abil-
ity of the model (simulated with such a set of parameter
values) to explain data from multiple mutant experi-
ments [25]. For each model of the clv1-1 mutant, the
parameter sets provide a semiglobal description of the
model behavior, instead of a more parameter value
dependent description that results if a single parameter
set would be used.
We apply statistical tools on the parameter sets to
obtain predictions about biological properties of the
stem cell regulating network resulting from introducing
the hypothesized mechanisms for the clv1-1 mutant.
Results and Discussion
We implemented the stem cell regulatory network as a sys-
tem of ordinary differential equations (ODEs) using stan-
dard mass action kinetics for molecular reactions (Figure 1,
Methods). The model consists of two receptors, CLV1 and
Sahlin et al. BMC Systems Biology 2011, 5:2
http://www.biomedcentral.com/1752-0509/5/2
Page 2 of 14CRN (representing the CRN/CLV2 receptor), that when
bound to CLV3 repress WUS expression, and WUS-
induced CLV3 expression.
Models of two clv1-1 hypotheses are both able to explain
data from wild type and six receptor mutant experiments
To objectively obtain parameter values we compared the
models with experimental data from wild type and the
four receptor loss-of-function mutants clv1-1, clv1-11,
crn-1,a n dcrn-1 clv2-1 (Methods). We implemented
clv1-11 and crn-1 clv2-1 as null mutants, removing the
receptors from the model, and the crn-1 as a complete
loss-of-signal mutant [9] (Methods). The clv1-1 mutant
is implemented either as a loss-of-signal mutant (loss-of-
signal model, Figure 1B) or by adding an interference
mechanism acting on the CRN receptor pathway (inter-
ference model,F i g u r e1 C ) .T oc o m p a r ep h e n o t y p i c
strength between a model and experiments, we used
WUS levels as a measure in the models and compared
with carpel numbers, which represent an experimental
estimate of phenotypic strength, see e.g. [9,15,19]
(Methods).
We used an optimization algorithm to find candidates
for parameter values [26] and performed multiple opti-
mizations to get an ensemble of parameter (value) sets
for each of the two models (Methods). We performed
25,000 optimizations for each model and kept only para-
meter sets for which the model was able to reproduce
data observed in the experiments (Figure 2). For the two
models the optimization algorithm found 21,968 (loss-
of-signal) and 23,121 (interference) valid parameter sets
(Figure 2).
Given that the number of parameters in the model
exceeded the number of available experiments, it was
important to lower the tendency of over fitting. Hence
we applied double mutants as an a posteriori validation
Figure 1 Illustation of the stem cell regulation models. A) A schematic drawing of the unperturbed stem cell regulation model. B-C)
Schematic drawings of the two different clv1-1 mutant models. B) In the loss-of-signal model the strength of the signal from the active CLV1-
receptor is affected. C) In the interference model the two receptors form a complex without function.
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data from the two double loss-of-function and null-
mutants crn-1 clv1-11 and crn-1 clv1-1 (Table 1), keep-
ing only parameter sets for which the models were able
to explain the double mutants (Figure 3). We observed
that for most parameter sets the models showed too
strong phenotypes for the double mutants (Figure 3),
and after the validation only 118 (loss-of-signal) and 531
(interference) parameter sets remained. The strong dou-
ble mutant phenotypes in the simulations can be
explained by the lack of other dynamic input to the
WUS repression in the model, except for the two path-
ways that are knocked out.
In conclusion, the loss-of-signal and interference mod-
els are both able to reproduce data seen in wild type,
four single receptor, and two double receptor mutant
experiments.
The loss-of-signal hypothesis implies sequestration of
CLV3 for the clv1-1 mutant
The difference between the two models is in the imple-
mentation of the clv1-1 mutant, which in each case is
described by a single parameter - k3, weak for the loss-of-
signal model and k8 for the interference model. For the
loss-of-signal model, we observed that the average
CLV1/CLV3 signal in the mutant (k3, weak) is an order
of magnitude smaller than the wild type signal (k3)
(Table 2), meaning that the model indeed shows a loss-
of-signal behavior. Likewise, we observed for the inter-
ference model that the average interference strength in
the mutant (k8) is an order of magnitude larger than the
receptor turnover rates (t1 and t2) (Table 2). This simple
sanity check confirmed that the hypothesized clv1-1 -
mechanisms were effective in the models when using
the parameter sets obtained from the optimization and
validation steps.
The stronger phenotype of the clv1-1 mutant requires
that the CRN pathway signal is weaker in the clv1-1
mutant compared with the clv1-11 null mutant. For the
interference model this requirement is fulfilled by the
interference mechanism itself since CRN receptors are
Figure 2 WUS equilibrium expressions in simulations of the clv1-1, clv1-11, crn-1,a n dcrn-1 clv2-1 single receptor mutants with the
loss-of-signal (A-B) and the interference (C-D) models. Parameter sets obtained from the optimization algorithm. Solid lines mark the regions
that were selected in the optimization step (Table 1).
Table 1 Mutants
Mutants Carpels/Flower SE Threshold error
Wild type 2.0 0.0 -
crn-1 3.9 0.1 0.1
clv1-11 3.9 0.1 0.1
crn-1 clv2-1 3.8 0.1 0.1
clv1-1 4.2 0.1 0.1
crn-1 clv1-11 5.3 0.1 0.5
crn-1 clv1-1 4.5 0.1 0.5
Experiments used in the optimization and validation steps to find parameter
values. The first four mutants (above the line) are single-receptor mutants and
are used in the optimization step. The remaining two double mutants are left
for the validation step. Carpel number values and standard errors are from [9].
The threshold errors are the errors used to find valid parameter sets in the
optimization and validation steps.
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mutated CLV1 in the clv1-1 mutant.
For the loss-of-signal mutant it is not as obvious how
the CRN pathway signal can be weaker in the clv1-1
mutant than in the clv1-11 null mutant, but since the
clv1-1 protein product still binds CLV3 it could sequester
CLV3, making it unavailable for the CRN pathway. This
would indirectly affect the signal strength of the CRN
pathway. For the clv1-11 null mutant no CLV1 is present
to bind to CLV3 leading to an increase of bound CRN
receptors. To verify this intuitive explanation, we investi-
gated the amounts of free CLV3 and bound CRN recep-
tors in the different clv1 mutants. As expected we
observed that both models had a lower amount of bound
CRN receptors in the clv1-1 mutant than in the clv1-11
null mutant (Figure 4A and 4C), although the mechan-
isms for achieving this differed. Furthermore, the clv1-1
loss-of-signal mutant had lower levels of free CLV3, con-
firming the sequestration of CLV3 (Figure 4B). In con-
trast, for the interference model we observed no signs of
CLV3 sequestration (Figure 4D).
Taken together these results show that the loss-of-sig-
nal model utilizes sequestration of CLV3 in the clv1-1
mutant in order to generate a stronger phenotype than
the clv1-11 null mutant. The interference model, on the
other hand, uses interference between the receptor path-
ways and simulations suggest that the model is less con-
strained by experimental data to achieve this result (cf.
F i g u r e s4 Aa n d4 C ) ,a sw a sa l s oi n d i c a t e db yt h en u m -
ber of parameter sets that passed the validation step for
the two models.
The two clv1-1 hypotheses leads to differences in
properties of the unperturbed stem cell regulating
network
Each model had a large ensemble of parameters after
the optimization and validation steps. Since the wild
type stem cell regulating networks of the two models
are identical, there are no a priori reasons for the para-
meter values of the models - excluding the parameters
unique for each implementation of the clv1-1 mutant -
to differ. To analyze differences in parameter values we
generated a hypothesis-neutral background distribution
by optimizing the model without using the clv1-1
mutant. We performed 25,000 optimizations and for
24,686 parameter sets the model was able to reproduce
the wild type and the three single mutant experiments.
These parameter sets were used as a background
Figure 3 WUS equilibrium expressions in simulations of the crn-1 clv1-11 and crn-1 clv1-1 double mutants with the loss-of-signal
(A) and the interference (B) models with the parameter sets obtained from the optimization step. Solid lines mark the regions that were
selected in the validation step (Table 1).
Table 2 Model parameters
Loss-of-signal Interference
Parameter Mean value Sensitivity Mean value Sensitivity
k1 2.6 ± 2.4 -0.35 ± 0.14 1.2 ± 0.6 -0.48 ± 0.10
k2 1.4 ± 1.0 0.12 ± 0.08 2.2 ± 1.4 0.32 ± 0.12
k3 3.6 ± 1.5 -1.0 ± 0.10 1.7 ± 0.9 -0.85 ± 0.13
k4 1.3 ± 0.9 -0.44 ± 0.10 1.0 ± 0.5 -0.49 ± 0.09
k5 2.3 ± 1.4 0.33 ± 0.12 2.3 ± 1.4 0.35 ± 0.10
k6 2.3 ± 1.2 -0.81 ± 0.08 1.8 ± 0.9 -0.77 ± 0.06
k7 1.2 ± 0.7 0.85 ± 0.13 1.3 ± 0.8 0.91 ± 0.09
K 2.47 ± 1.17 2.5 ± 0.6 2.2 ± 0.9 2.5 ± 0.7
n 5.1 ± 1.3 -0.19 ± 0.04 4.4 ± 1.2 -0.29 ± 0.08
t1 2.6 ± 1.2 0.61 ± 0.17 0.95 ± 0.48 0.32 ± 0.20
s1 1.3 ± 0.7 -0.62 ± 0.11 2.3 ± 1.0 -0.69 ± 0.08
t2 0.77 ± 0.55 0.24 ± 0.12 0.71 ± 0.36 0.21 ± 0.09
s2 1.9 ± 0.9 -0.67 ± 0.09 2.0 ± 0.9 -0.69 ± 0.05
t3 1.8 ± 0.9 -0.36 ± 0.21 3.9 ± 2.2 -0.15 ± 0.18
s3 2.1 ± 1.2 -1.2 ± 0.3 1.5 ± 0.6 -1.1 ± 0.2
t4 1.6 ± 0.8 1.8 ± 0.1 1.2 ± 0.6 1.6 ± 0.2
s4 0.65 ± 0.33 -0.76 ± 0.51 0.76 ± 0.35 -0.87 ± 0.59
dW 2.4 ± 2.2 -0.85 ± 0.12 2.1 ± 1.4 -0.90 ± 0.08
kW 1.4 ± 1.0 -0.15 ± 0.13 1.3 ± 0.84 -0.088 ± 0.088
k3, weak 0.15 ± 0.13 –– –
k8 –– 5.6 ± 4.8 –
Model parameter properties for parameter sets remaining after the validation
step. Mean value columns: Averages and standard deviations of parameter
values. Sensitivity column: Averages and standard deviations of wild type
WUS sensitivities (Eq. 21). (loss-of-signal 118 parameter sets, interference 531
parameter sets).
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ceeding analysis.
We performed a Principal Component Analysis (PCA)
on the joint parameters of the models. Interestingly, we
observed that there was a clear separation both between
the distributions coming from the two models, and
between those of the individual models and the back-
ground distribution (Figure 5A). This showed that the
introduction of the two hypotheses for the clv1-1
mutant leads to differences in the properties of the
unperturbed stem cell regulating network.
To further analyze the differences between the models
we compared each parameter individually between the
two models and the background by using receiver oper-
ating characteristics (ROC) curves, where we used the
area under the ROC-curve (AUC) to quantify differences
between the three parameter distributions (Methods)
[27]. We generated sorted lists of the AUC values
(Table 3), and some parameters showed differences
between either clv1-1 model and the background.
To highlight features of each model we studied the para-
meters that differed the most in more detail to find out
how they relate to biological mechanisms. We noted that
the Hill parameters (K and n) were among the top candi-
dates for both hypotheses (Table 3). These parameters
tune the regulation of WUS by the combined pathway
(Methods). The validation step did introduce large con-
straints on the parameters (Figure 3), and it is likely that
fitting the parameters to the double mutant experiments
led to a tighter regulation of the Hill parameters. To con-
firm this, we did an AUC parameter comparison between
data after the optimization step and data after the valida-
tion step, wherein both Hill parameters appeared among
the top three parameters (data not shown). We also did an
AUC comparison between the two models’ data sets, and
in this case the Hill parameters did not show up at the top
of the list (data not shown). As a consequence of these
results we did not look further into these two parameters,
but focused on the receptor ligand dynamics.
We chose, somewhat ad hoc, to make a cut in AUC at
0.75 for this analysis. The comparison between the loss-
of-signal hypothesis and the background emphasized
two parameters. the strength of the CLV1/CLV3 signal
into the cell (k3) and the CLV1 turnover rate (t1) (Figure
5 B - C ) .T h ec o m p a r i s o nb e t w e e nt h ei n t e r f e r e n c e
hypothesis and background also highlighted two para-
meters, which in this case were the production rates for
the two receptors (s1, s2) (Figure 5D-E).
In conclusion we have shown that parameter calibra-
tion of the different implementations of the clv1-1
mutants imposes non-expected constraints on the para-
meters of the two models, and in the further analysis we
found four parameters that were the most discriminat-
ing between the models. These four parameters will be
used in the proceeding analysis to evaluate their conse-
quences from a biological perspective.
Figure 4 Equilibrium concentrations of bound CRN receptors and free CLV3 in simulations of the clv1-1 and clv1-11 mutants of the
two models. A-B) Loss-of-signal model. C-D) Interference model. A) and C) Concentrations of bound CRN. B) and D) Concentrations of bound
CLV3.
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pathways with a slightly stronger CLV1-dependence
The parameter that differed the most in the comparison
between the loss-of-signal and background distributions
was k3 (Table 3), wherein it was larger for the loss-of-
signal model. This is not surprising since k3 sets the
strength of the signal from the bound CLV1 receptor
and the loss-of-signal mutant needs to be able to reduce
this signaling strength for the clv1-1 mutant.
The selection of k3 m a ya l s ob ea ni n d i c a t i o nt h a ti ti s
important for the loss-of-signal model that the CLV1/CLV3
pathway is stronger than the CRN/CLV3 pathway. In our
Figure 5 Comparisons of parameter values between the loss-of-function and interference models and strengths between the CLV1
and CRN receptor pathways. A) Parameter sets for the two models and the background distribution presented with the help of a PCA-
analysis. The parameter sets are projected on the two largest principal components (E1 and E2). B-E) Distributions of parameter values of
parameters highlighted in the analysis step. B-C) Comparing parameter value distributions of parameters k3 (B) and t1 (C) for the loss-of-signal
model (black) and the background distribution (gray). D-E) Comparing parameter value distributions of parameters s1 (D) and s2 (E) for the
interference model (white) and the background distribution (gray). Axes have log-scale and have ranges [0.23, 12] (B), [0.082, 9.9] (C), [0.24, 9.5]
(D), and [0.21, 7.6] (E). Corresponding ROC-curves are presented in each plot with axes ranging from 0 to 1.0. F-H) The parameters k3 and k6 set
the strengths of the signals from bound CLV1 and CRN receptors. To compare the strengths of the two receptor pathways we plot each
parameter multiplied with respective concentration of bound receptors. The comparison is done for the loss-of-signal model (F), the interference
model (G), and the background distribution (H). Number of parameter sets for which the CRN pathway is stronger than the CLV1 pathway: Loss-
of-signal - 0 (0%), Interference - 17 (3.2%), Background - 1696 (6.9%).
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times the concentration of bound CLV1 receptors, and the
latter is given by k6 times the concentration of bound CRN
receptors. We observed that the CLV1 pathway indeed was
slightly stronger for both models (Figure 5FH) and this
effect was somewhat stronger for the loss-of-signal model.
However, the asymmetry between the two pathways was
fairly small and it is obvious that the WUS-repressing signal
is dependent on both pathways. By only considering the
wild type network, one might assume that using double
pathways would mean that the strengths of the two could
be freely tuned. if the strength of one of the pathways is
increased, the increase could be compensated by decreasing
the other to obtain the same combined signal. This was
however not what we observed in our analysis. In contrast,
when also taking the mutants into account it is important
to divide the signal evenly between the two pathways, but
with a slightly stronger CLV1 pathway signal (Figure 5F-H).
This is true for both models, as was also suggested by the
mutant experiments since the clv1 phenotypes are slightly
stronger than the crn phenotypes (Table 1).
Degradation or internalization of the bound receptor is
implicated by the loss-of-signal clv1-1 hypothesis
The second parameter highlighted for the loss-of-signal
model, from the comparison with the background
distribution, was t1 (Table 3). The t1 parameter sets the
turnover rate of the CLV1 receptor, including the degrada-
tion of the bound receptor (Methods). The loss-of-signal
model typically had a larger value of this parameter. Inter-
estingly, this was in accordance with our finding that the
loss-of-signal model without degradation of the bound
CLV1 receptor could not cohere with all mutant data
simultaneously (data not shown). Together these results
p r e d i c tt h a tf o rt h el o s s - o f - s i g n a lm o d e lt ow o r kt h e
bound CLV1 receptor needs to be removed from the
membrane, possibly via internalization.
Receptor trafficking has been suggested to be important
for several cell-signaling pathways [28] and endosomal
functions play major role in plants [29]. Although there
has been no experimental evidence for CLV1 internaliza-
tion, other receptors such as FSL2 and BRI have been
shown to be internalized [29]. Recent GFP-data of CLV1
indicates that CLV1 is located mainly in the plasma mem-
brane but can also be found in internal cell compartments
[10]. The model suggests that there should be a non-negli-
gible rate of internalization of the bound CLV1 receptor.
The interference hypothesis leads to large quantities of
receptors
From the comparison between the interference model
and the background distribution it was seen that the
parameters for receptor production, s1 and s2,a r el a r g e
in the interference model (Table 3). This suggests that
the interference model requires large quantities of
receptors to reproduce the differences in phenotype of
the clv1-1 non-null mutant and the clv1-11 null mutant.
An explanation could be that there must be enough
receptors available for the interference mechanism to be
efficient. When comparing the amount of free receptors
with the amount of free CLV3 in wild type simulations,
we observed that there was an abundance of receptors
(Figure 6A). It can be noted that large quantities of both
receptors are present (data not shown). As a compari-
son, the background distribution data did not show any
bias towards an abundance of free receptors (Figure 6C).
In addition, we compared the amount of bound versus
free receptors (Figures 6B and 6D), and only the inter-
ference model data displayed a bias towards more free
than bound receptors in the wild type simulations. From
a biological point of view, the strategy of having large
amounts of free receptors might not be advantageous
given the metabolic cost associated with the production
of receptors. However, the optimization algorithm does
not take metabolic costs into consideration and it might
be that, if it had, the result could be different. The addi-
tion of metabolic cost would be an interesting improve-
ment of the optimization algorithm that could be tested.
At this point, we have examined all parameters high-
lighted by the AUC value, but our threshold value for
Table 3 AUC comparisons
Loss-of-signal vs. Background Interference vs. Background
Name Relation AUC Name Relation AUC
n LOS > Bg 0.93 n I > Bg 0.88
k3 LOS > Bg 0.86 K I > Bg 0.77
K LOS > Bg 0.84 s1 I > Bg 0.76
t1 LOS > Bg 0.83 s2 I > Bg 0.75
s2 LOS > Bg 0.70 s3 I < Bg 0.71
k5 LOS > Bg 0.67 k2 I > Bg 0.67
t4 LOS > Bg 0.66 dW I > Bg 0.66
k1 LOS > Bg 0.65 k5 I > Bg 0.66
t3 LOS < Bg 0.64 t3 I > Bg 0.66
s3 LOS < Bg 0.63 t4 I > Bg 0.61
s4 LOS < Bg 0.61 kW I < Bg 0.60
dw LOS > Bg 0.61 k7 I < Bg 0.58
k7 LOS < Bg 0.58 k4 I < Bg 0.58
kW LOS < Bg 0.57 s4 I < Bg 0.57
k2 LOS > Bg 0.57 k1 I < Bg 0.57
k4 LOS < Bg 0.56 k3 I > Bg 0.56
t2 LOS > Bg 0.56 k6 I > Bg 0.56
k6 LOS > Bg 0.54 t2 I > Bg 0.54
s1 LOS > Bg 0.51 t1 I < Bg 0.53
The results from the analysis step, comparing parameter value distributions of
the two models with the background distribution. Parameters are sorted by
area under ROC curves (AUC). The parameters under the line have a p-value
greater than 0.05 and are not statistically significant, where p-values are
calculated with a Wilcoxon rank-sum test. See also Fig. 5.
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Hence it could be of interest to briefly investigate the
parameters that follow in the sorted list (Table 3). The
CLV3 production rate (s3) is lower and the unbinding
rate of the CLV1/CLV3 complex (k2)i sh i g h e rf o rt h e
interference model compared to the background distri-
bution, acting in directions of having low CLV3 and
much unbound receptor, strengthening the conclusions
in this section. For the loss-of-function model the CRN
production rate (s2) and the unbinding rate of the CRN/
CLV3 complex (k5)a r eh i g h ,a c t i n gi nt h ed i r e c t i o no f
having much unbound CRN, which we could see in the
simulated data (data not shown). Unbound CRN acts in
favor of CLV3 sequestration in the clv1-1 mutant,
strengthening our sequestration discussion above.
In conclusion, our model analysis pinpointed the
receptor abundance as important for both receptors in
the interference model and also for the CRN receptor in
the loss-of-function model. It would be interesting to
see how these predictions relate to experimental data,
especially the somewhat counterintuitive prediction that
there is a large pool of inactivated receptors.
Additional perturbations
Although the CLV3 feedback is simplified in the model
(Methods), it is of interest to analyze the model beha-
vior for different CLV3 perturbations since these have
been extensively studied in experiments. Loss-of-func-
tion clv3 mutants show an increase in WUS expression,
and gain-of-function mutants repress WUS [4-6].
Figure 6 Receptor concentrations from simulations and CLV3 perturbation simulations. A-D) Study of the amount of free receptors
compared with the amounts of bound receptors and free CLV3. A and C) Concentrations of free CLV3 compared with amounts of free receptors
in simulations of wild type with the interference model (A) and the background distribution (C). B and D) Amounts of bound receptors
compared with amounts of free receptors in simulations of wild type with the interference model (C) and the background distribution (D). E-F)
Study of CLV3 over- and underexpression. The parameters s3 and kW are multiplied by a factor (presented as the abscissa). The perturbed WUS
expression is then normalized with the unperturbed WUS expression (presented as the ordinate). Presented data is average and standard
deviation of normalized equilibrium WUS expressions in simulations of wild type with the loss-of-signal model (E) and the interference model (F).
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changed an order of magnitude up and down are pre-
sented in Figure 6E. The models correctly predicted an
increase of WUS as the CLV3 was lowered and a
decrease when CLV3 was increased. However, it has been
shown in more detailed CLV3 perturbation experiments
that it is possible to change CLV3 expression strength
over a large range without any apparent phenotypical
effects [30]. This was not captured in our CLV3 pertur-
bation simulations (Figure 6E-F) and hence the model
only qualitatively predicted the perturbations. This did
not come as a surprise since we have focused our investi-
gations on receptor mutants a n dw eu s e dad i r e c tl i n e a r
WUS-dependent activation of CLV3. In reality CLV3 is
expressed in different cells compared to WUS and the
(still unknown) regulation is possibly nonlinear. To intro-
duce a spatial model would however require additional
assumptions and hypotheses (Methods).
We also did a sensitivity analysis of individual para-
meters and both models were robust to changes in most
parameters (Table 2, Methods), an important feature
given that the stem cell regulation needs to be robust to
environmental changes and stable over long periods of
time.
Conclusions
The stem cell regulation network in the plant shoot api-
cal meristem is a well-studied system given its necessity
for aboveground plant development. The large amount
of mutant phenotype data available together with several
gaps in knowledge of network details call for computa-
tional modeling as a tool for understanding the complex
regulation at a systems level.
We have developed a model for the stem cell regula-
tion network based on the negative feedback loop
between CLV3 and WUS and focused on CLV3-receptor
dynamics and mutants. The model takes into account a
negative regulation of WUS via two different - although
merging - receptor pathways, CLV1 and CRN, as well as
a WUS-induced CLV3 production. Starting from the
question how the clv1-11 null mutant can be weaker in
phenotype compared to the non-null clv1-1 mutant, we
scrutinized two models implementing different hypothe-
sized mechanisms for the clv1-1 mutant.
In the first tested mechanism for clv1-1, the mutated
CLV1 product interfered with the CRN pathway, as pre-
viously suggested [30]. Due to the interference, the CRN
signal is decreased in the clv1-1 mutant, as compared to
the null mutant. Since both pathways are decreased the
phenotype becomes stronger. We could also conclude
that this hypothesis led to the prediction that there is an
abundance of receptors in relation to CLV3.
In the second model the clv1-1 mutant was implemen-
ted as a loss-of-signal mutant, i.e. the receptor still binds
CLV3 but no signal is propagated. We showed that the
CRN signal is decreased in the clv1-1 mutant compared
to the null mutant due to sequestration of CLV3 by the
continued binding to the CLV1-receptor. For this model
to work it is necessary that the bound CLV1 receptor is
internalized or degraded.
The adopted approach for extracting parameter
ensembles and using statistical methods when compar-
ing different hypotheses is generally applicable for sys-
tems biology modeling and provides an objective
approach for dealing with unknown parameters. A
future improvement could be to adopt machinelearning
techniques of cross-validation by selecting different
mutants to be included in the optimization and valida-
tion sets and then merge into a single parameter
ensemble.
Our model represents a simplification of the system,
most notably by disregarding spatial factors and not
including all possible receptors and additional mechan-
isms known to be important for WUS regulation. How-
ever, these simplificationsa l l o w e du st oi n v e s t i g a t e
multiple receptors with an almost complete set of recep-
tor mutants. We were not able to discard any of the two
clv1-1 h y p o t h e s e s ,b u ts t i l lw ew e r ea b l et od e l i v e r
experimentally verifiable predictions for both hypoth-
eses, also on general properties of the stem cell regulat-
ing network that are indirect consequences of the
hypotheses that would have been difficult to predict by
intuition alone. The loss-of-signal mechanism has the
advantage that it is more parsimonious since it only
affects the signaling capacity, which fits well with the
allele’s known mutation in the kinase domain. The
interference mechanism, on the other hand, is less con-
strained and seems to have an easier task in producing
the mutant results. In the end it is experiments that
should resolve the issue and we hope that this investiga-
tion can serve as an inspiration both for new experi-
ments and for modelers to include multiple receptors in
models of plant stem cell regulation.
Methods
Models
In our models CLV3 binds to the receptors CLV1 and
CRN and thereby activates them. Activated CLV1 and
CRN contribute to a signal X, which inhibits expression
of WUS. WUS promotes production of CLV3 and there-
fore enables for a selfregulating system. CLV3, the
receptors CLV1 and CRN, and the signal X all have a
basal level of production, while WUS has basal produc-
tion that can be repressed by the X signal. All molecules
have a concentration-dependent degradation rate. See
Figure 1A for a schematic drawing of the wild type
model. We use mass action kinetics to get a mathemati-
cal representation of the model in the form of a system
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the equations are
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where [CLV1] and [CRN] are concentrations of
unbound receptors, [CLV3] is the concentration of the
CLV3 peptide, [CLV1/CLV3] and [CRN/CLV3] are con-
centrations of bound receptors, [X] is the concentration
of the signal X, and [WUS] is the concentration of the
transcription factor WUS.
The parameters k1, k2, k4,a n dk5 are reaction con-
stants for binding of CLV3 to CLV1 and CRN. The
parameters k3 and k6 set the strengths of the signals
from the activated receptors to the signal X. Production
and degradation of CLV1, CRN, CLV3, and X are deter-
mined by the parameters t1, s1, t2, s2, t3, s3, t4,a n ds4,
while dw sets degradation of WUS. Production of WUS,
downregulated by X, is controlled by parameters k7, K,
and n. Note that we do not have experimental estimates
of parameter values and it is mainly the relation
between parameters that is of importance; hence we
refrain from specifying unit values on our parameters.
Our model is to be seen as a simplification of the
SAM. The SAM is divided into several spatial regions
each characterized by different gene expression patterns.
Cells in the SAM also divide with time and move
between different regions. We do not address the posi-
tioning associated with the different expression domains.
While WUS, CLV1, and CRN are expressed in the same
cells, CLV3 is not [2,3]. We include a simplified CLV3
feedback via a direct connection from WUS and a direct
binding of CLV3 to the receptors. The rationale for this
simplification is that the way the spatial signals are pro-
pagated is not fully understood and would require add-
ing multiple additional hypotheses (see e.g. [21-23]).
Our implementation still covers the main feedback
interactions needed to investigate the behavior of the
different receptor mutants that are the main target of
this work. The internal part of the signaling pathway is
in our model described by a single signal X. Although
the POL/PLL1 has been shown to be important for
mediating the signal [14], the details of the architecture
is unknown and we point this out by instead represent-
ing the signal with X.
The state of the CLV signaling network is in our
model measured via WUS expression levels. The expres-
sion of WUS and CLV3 is altered in the SAM when
CLV signaling is perturbed, both by expanding/decreas-
ing expression regions and by increasing/decreasing
levels [18]. Our WUS measure serves as a simplification
of this.
Mutants
We are interested in several receptor mutants and we
implement them in different ways. The clv1-11 and crn-
1 clv2-1 mutants are both modeled by removing all pre-
sence of CLV1 ([CLV1] = [CLV1/CLV3] = 0) and CRN
([CRN] = [CRN/CLV3] = 0) respectively. The crn-1
mutant is modeled by setting k6 =0 .T h er e m a i n i n g
mutant of interest - clv1-1 - is treated differently in two
models.
In the loss-of-signal model the parameter k3 is
replaced by another parameter k3,weak for the clv1-1
mutant (Figure 1B).
In the interference model an extra mechanism is
introduced (Figure 1C). For the clv1-1 mutant, the
receptors CLV1 and CRN can form a complex and
when they do the complex is discarded. Mathematically
an extra term is added to the time derivative of CLV1
and CRN,
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Computational Procedures
Our approach can be divided into three steps; an opti-
mization step, a validation step, and an analysis step. In
the optimization step we use an optimization algorithm
to find parameter (value) sets for which the models can
reproduce the wild type and the four loss-of-function
m u t a n t s .I nt h ev a l i d a t i o ns t e pw ec h o o s et h es u b s e to f
these parameter sets for which the models also explain
the two double mutants. In this way we reduce the pro-
blem of over- fitting to data, which usually hampers the
predictive power of the models.
After the validation step a large number of possible
parameter sets remain. Instead of the more usual
approach of just choosing the parameter set for which
the model best matches experimental data, we keep all
parameters and look at the ensembleoutput of the
model. In this way we get semi-global robust predictions
of the model behavior. However, this leaves us with lots
of possible parameter sets that require further analysis.
In the analysis step of our computational approach we
deploy a number of computational and statistical tools
to analyze the ensemble of obtained parameter sets. In
this way we are trying to further analyze the behavior of
the models to find significant differences.
Optimization
A Simulated annealing algorithm was used to fit para-
meters to experimental data [31]. The algorithm is
divided into four steps.
1. An initial set of parameters, pinitial,i sr a n d o m l y
chosen from a uniform distribution.
2. A proposed new set of parameters pnew is chosen
by randomly picking a parameter and changing its
value by multiplying or dividing (with equal prob-
ability) with a factor 1.01. An associated energy is
calculated by a parameterdependent energy (objec-
tive) function E = E(p) (see below).
3. The new parameter set, pnew, is kept with a prob-
ability Pe
Ep Ep new old =
−− min( , )
(( ) ( ) ) 1
 ,w h e r eb is a
positive parameter inversely proportional to a virtual
temperature.
4. Step 2-3 is repeated while b is being increased
every thousand iterations by a factor 1.1, starting
from 1 until it ends at 10,000.
At each iteration, the energy associated with the cur-
rent parameter set is compared with the overall best
performing parameter set, i.e. the parameter set with the
lowest corresponding energy. When b reaches its maxi-
mum value the algorithm stops and the best performing
parameter set is used as the solution to the optimization
problem.
Each optimization gives a proposed parameter set.
After each optimization the parameter set is tested with
the model against the experimental data. If the model is
able to reproduce the experimental data within the
errors supplied the parameter set is kept, otherwise it is
discarded.
Energy function
To compare phenotypic strength between models and
e x p e r i m e n t s ,w eu s eW U Sl e v e l sa sam e a s u r ei nt h e
models and compare with carpel numbers from experi-
ments. Carpel numbers have been used extensively in the
literature as a measure of the phenotypic strength of per-
turbations to the CLV signaling network (see e.g. [9,19],
and [15] for an example where both RT-PCR measure-
ments of WUS and carpel numbers are reported).
To calculate the energy for a given parameter set we
first calculate the equilibrium of WUS concentration,
[WUS]*, for the wild type experiment, and for the crn-1,
clv1-11, crn-1 clv2-1,a n dclv1-1 mutant experiments.
The WUS levels for the mutant experiments are
normalized with the wild type WUS level. The energy
function is defined as
ED ii
i
=−
∗ ∑(, []) WUS
2
(10)
where [WUSi]* is the normalized equilibrium WUS
expression for experiment i, Di is the expected value
from experiment, and the summation is over all mutant
experiments. The experimental values that we have used
to find parameters are presented in Table 1[9].
Validation
To reduce overfitting we leave two double mutant
experiments out of the optimization step and instead
use them for a validation step. Simulations of two dou-
ble mutants crn-1 clv1-11 and crn-1 clv1-1 for the two
models are compared with experimental data to find
parameters that can be used to reproduce the behavior
of both the single and double mutant experiments. In
the validation step we use a larger threshold for validat-
ing simulations compared to what was used in the opti-
mization step (Table 1).
Numerical solutions
We are interested in fixed point solutions to the system,
which are obtained by solving the system of equations
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brium the fixed point concentrations [X]*, [CLV1/
CLV3]*, and [CRN/CLV3]* are equal to
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The three fixed point concentrations [CLV1]*, [CRN]*,
and [CLV3]* are given by the solution to the system of
equations
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with k8 ≠ 0f o rt h eclv1-1 mutant in the interference
model and k8 = 0 otherwise, and where
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The equilibrium expression of WUS, [WUS]*, is the
solution to
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To numerically find the equilibrium concentrations we
first consider Eq. 18 as a function f of WUS expression
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where X* = X*([WUS]) is a function of WUS given by
Eqs. 11-16. The equation f([WUS]) = 0 is solved
numerically by the bisection method [31]. As an inter-
mediate step we solve the system of equations, Eqs. 14-
16, with Newton’s method [31]. We define equilibrium
as follows; the Newton’s method iterates until |e|<
0.001, where
e = ⎛
⎝
⎜
⎞
⎠
⎟
d
dt
d
dt
d
dt
[]
,
[]
,
[]
,
CLV CRN CLV 13
(20)
and the bisection method iterates until |f([WUS])| <
0.0001.
Sensitivity analysis
The models’ robustness to parameter perturbations were
tested by a sensitivity analysis [32]. If M is a quantity of
the system and p is a parameter, the sensitivity Sp is
defined as
S
M
p
p
M
p =
∂
∂
. (21)
The absolute value of Sp serves as a measurement of
how sensitive M is to perturbations in parameter p.A
greater value corresponds to a greater sensitivity. The
sign of Sp tells if the response is positive or negative in
respect to a positive change of the parameter. We use
the equilibrium WUS concentration for the wild type
network for our measurable quantity during our sensi-
tivity analysis (Table 2). Both models were robust to
changes in most parameters. The only parameters that
h a das e n s i t i v i t ys i g n i f i c a n t l ya b o v eo n ew e r eK and t4,
both parts of the pathway between the signal and the
WUS expression. This part of the model is a crude
approximation of the internal pathway architecture. The
internal signaling pathway was also highlighted when
comparing differences in parameters (cf. n and K in
Table 3), which indicates the importance to further
investigate this part of the network, both in experiments
and by modeling.
Receiver operating chacteristic curves
A receiver operating characteristic (ROC) curve mea-
sures the overlap of the distributions of two data sets
Aa n dB .T h ea r e au n d e rt h eR O C - c u r v e s( A U C )q u a n -
tifies differences between A and B independent of the
number of parameter sets within the distributions [27].
By calculating the AUC we get a value between 0 and
1, where 0 means that the values of data set A are all
greater than those of data set B, 0.5 means that the
two sets come from the same distribution, and 1
means that all values of data set B are greater than
t h o s eo fd a t as e tA .
Availability
The optimization algorithm, the numerical solver, and
the statistical tools are in house implementations and
are publicly available upon request. Operating system(s).
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Page 13 of 14Platform independent; Programming language. C++;
Licence. no licence needed.
Parameter data can be found at http://www.thep.lu.se/
~henrik/clvCrn/.
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